Our findings support a permissive role for the endocannabinoid system in the maintenance of hypertension and metabolic syndrome in (mRen2)27 rats, consistent with emerging evidence for common signaling pathways between the endocannabinoid system and the RAS that may promote or enhance Ang II‐related pathologies. The gene discussed is AGT; the disease is metabolic syndrome.